Helicobacter Pylori Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori
Condition: The Eradication Rate of Helicobacter Pylori Interventions: Drug: Vonopazan +Amoxicillin; Drug: Rabeprazole +colloidal pectin bismuth +Amoxicillin +Clarithromycin; Drug: Vonopazan +Minocycline; Drug: Rabeprazole +colloidal pectin bismuth +Metronidazole +Clarithromycin Sponsor: Shanghai Changzheng Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori (SHARE2302)
Condition: Helicobacter Pylori Infection Interventions: Procedure: 7days bismuth quadruple; Procedure: 14 days bismuth quadruple Sponsors: Shandong University; Zibo Maternal and Child Health Hospital; Zaozhuang Municipal Hospital; Binzhou Maternal and Child Health Hospital; Jinxiang County People's Hospital; Linyi Yizhou Hospital; Yantai Penglai Traditional Chinese Medicine Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials